» Articles » PMID: 15512850

Vasopressinergic Regulation of the Hypothalamic Pituitary Adrenal Axis and Stress Adaptation

Overview
Journal Stress
Publisher Informa Healthcare
Specialties Biology
Neurology
Date 2004 Oct 30
PMID 15512850
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Vasopressin (VP) stimulates pituitary ACTH secretion through interaction with receptors of the V1b subtype (V1bR, V3R), located in the plasma membrane of the pituitary corticotroph, mainly by potentiating the stimulatory effects of corticotropin releasing hormone (CRH). Chronic stress paradigms associated with corticotroph hyperresponsiveness lead to preferential expression of hypothalamic VP over CRH and upregulation of pituitary V1bR, suggesting an important role for VP during adaptation of the hypothalamic-pituitary-adrenal (HPA) axis to stress. Vasopressinergic regulation of ACTH secretion depends on the number of V1bRs as well as coupling of the receptor to phospholipase C (PLC) in the pituitary. Regulation of V1bR gene transcription may involve a number of regulatory elements in the promoter region, of which a GAGA box was shown to be essential. Although V1bR gene transcription is necessary to maintain V1bR mRNA levels, the lack of correlation between VP binding and V1bR mRNA suggests that regulation of mRNA translation is a major regulatory step of the number of V1bRs. V1bR translation appears to be under tonic inhibition by upstream minicistrons and positive regulation through protein kinase C (PKC) activation of an internal ribosome entry site (IRES) in the 5' untranslated region (5'UTR) of the mRNA. The data provide mechanisms by which regulation of hypothalamic VP and pituitary V1bR content contribute to controlling HPA axis activity during chronic stress.

Citing Articles

THE ROLE OF PLASMA COPEPTIN LEVEL IN DETERMINING THE SEVERITY AND MORTALITY OF SUBARACHNOID HEMORRHAGE.

Ozkan S, Baykan N, Salt O, Yakar S, Sen A, Durukan P Acta Clin Croat. 2025; 62(4):595-604.

PMID: 39866759 PMC: 11759122. DOI: 10.20471/acc.2023.62.04.3.


CRHBP, a novel multiple cancer biomarker connected with better prognosis and anti-tumorigenicity.

Yoo W, Choi H, Lee J, Lee Y, Park K, Noh K Cancer Cell Int. 2024; 24(1):391.

PMID: 39614295 PMC: 11607943. DOI: 10.1186/s12935-024-03562-4.


Establishment and Clinical Application in Stroke of a Serum Copeptin Time-Resolved Fluorescence Immunoassay.

Zhou Z, Sun F, Jiang J, Dou Z, Lv Y, Zhang Z J Fluoresc. 2023; 34(5):2349-2358.

PMID: 37782447 DOI: 10.1007/s10895-023-03441-7.


[Oxytocin and vasopressin: sexual differences and clinical implications].

Mondragon-Ceballos R, Barrios-De Tomasi J, Hernandez-Lopez L Rev Med Inst Mex Seguro Soc. 2023; 61(2):196-203.

PMID: 37200960 PMC: 10395999.


Copeptin: A potential marker for the prediction of poor ovarian reserve in the ınfertile women.

Gorkem U, Yildirim E Turk J Obstet Gynecol. 2022; 19(4):281-286.

PMID: 36511599 PMC: 9748858. DOI: 10.4274/tjod.galenos.2022.55856.